Navigation Links
Genedata Launches Expressionist with Expanded Mass Spectrometry Biomarker Discovery Capabilities
Date:6/1/2009

Genedata Expressionist 5.2 with enhanced capabilities for Mass Spectrometry-based biomarker discovery will be demonstrated at the 57th ASMS Conference on Mass Spectrometry, May 31 - June 4, 2009, Booth# 133 at the Pennsylvania Convention Center.

Philadelphia, PA (PRWEB) June 1, 2009 -- Genedata, a leading provider of in silico solutions for pharmaceutical R&D and related life sciences, today announced the release of Expressionist 5.2 with enhanced capabilities for Mass Spectrometry (MS)-based biomarker discovery. Included in the Expressionist system are the advanced Refiner MS and Analyst modules, which process and analyze metabolomic and proteomic raw MS data and provide sophisticated statistical analysis capabilities for large volume data sets. Expressionist 5.2 will be demonstrated at the 57th ASMS Conference on Mass Spectrometry, May 31 - June 4, 2009, Booth 133 at the Pennsylvania Convention Center.

"Genedata's continued investment in Expressionist is invaluable and the new Expressionist system will drastically change the ways in which we are able to probe experimental systems," commented Professor James Mobley, director of the Comprehensive Cancer Center Proteomics Facility at the University of Alabama. "Expressionist enables us to better understand underlying biological mechanisms and the support for labeled MS data allows us to address an ever-larger array of experimental protocols."

In addition to supporting ABI Wiff files, version 5.2 of Refiner MS adds Thermo Exactive and GC-MS as well as Agilent Q-TOF and GC-MS instruments to the wide list of already supported hardware platforms and vendor formats. Building on a powerful technology hub concept for raw MS data processing, peak identification and annotation tools in Expressionist have been enhanced to offer direct links to search engines and databases such as MASCOT or HMDB. Additionally, improved library searches are possible via the computation of retention-time indices.

"The release of Expressionist 5.2 underscores our continued commitment to support all types of omics technologies. In particular we are proud to provide innovative software for high throughput peak processing and identification for large MS datasets at a time when this type of data has become more and more standard in proteomics and metabolomics projects," said Dr. Othmar Pfannes, CEO of Genedata. Expressionist features support for labelled workflows using Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) and Multiple Reaction Monitoring (MRM) targeted analysis. Usability improvements include blank chromatogram subtraction and spectrum peak clustering.

"We are delighted by the market acceptance of our MS offering for proteomics and metabolomics in pharmaceutical, biotechnology, agricultural and academic as well as government R&D projects," Dr. Pfannes continued. "I am proud of our team's ability to quickly provide solutions for a wide variety of requests for standardization and automation of MS data analysis processes."

Editorial Note: Genedata will be exhibiting at Booth 133 at the ASMS conference. To schedule a briefing and product demo, contact: Jackie Thrasivoulos, +1 508 881 3109.

About Genedata
Genedata develops and globally markets sophisticated computational solutions for drug discovery and related research processes in the life sciences. Genedata's solutions enable scientists to process, integrate, analyze, and manage large and complex experimental data sets generated by high throughput technologies. Solutions include Genedata Phylosopher® for target discovery and integrative biological data management, Genedata Screener® for automated high throughput screening and high content screening, and Genedata Expressionist® for biomarker discovery and personalized medicine. Founded in 1997, Genedata is privately held, with headquarters in Basel, Switzerland, and offices in Boston & San Francisco, USA, Konstanz & Munich, Germany and Tokyo, Japan. For more information, please visit www.genedata.com.

# # #

Read the full story at http://www.prweb.com/releases/Genedata/Expressionist/prweb2464444.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. Drug Information Association Launches New 45th Annual Meeting Online
2. ForteBio Launches New Assay Capabilities for High-Sensitivity Protein Quantitation and Fragment Screening on Its Octet(R) Platform
3. Smith & Nephew Endoscopy Launches the BICEPTOR(TM) Tenodesis System, the First All-Arthroscopic Procedure for Biceps Tendon Repair
4. Angiotech launches e-commerce website that allows customers to order Quill(TM) SRS product line
5. Bioniche Pharma Launches Enlon(R) and Enlon-Plus(R) Injection
6. WellGen, Inc. Launches Te Ame(TM) Nutritional Supplements With Proven Health Benefits of Proprietary Black Tea Extract
7. Amnis Launches New ImageStreamX Imaging Flow Cytometer
8. Xconomy Launches XSITE 2009; First Annual Xconomy Summit on Innovation, Technology, and Entrepreneurship at Boston University
9. Cyprotex Launches Cloe(R) Gateway, its Secure web Portal for Access to Cyprotex Services Including an Enhanced Version of Cloe(R) PK.
10. Tepha Partner Launches Novel Monofilament Absorbable Suture Utilizing Tephas Proprietary Biomaterial
11. Elsevier Launches Ten New eBook Specialty Collections on MD Consult
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016   EpiBiome , a precision ... million in debt financing from Silicon Valley Bank (SVB). ... and to advance its drug development efforts, as well ... "SVB has been an incredible strategic partner ... a traditional bank would provide," said Dr. Aeron ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... STACS DNA ... Technical Leader at the Arkansas State Crime Laboratory, has joined STACS DNA as a ... STACS DNA team,” said Jocelyn Tremblay, President and COO of STACS DNA. “In further ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
(Date:6/23/2016)... June 23, 2016 ... 2016;12(1):22-8 http://doi.org/10.17925/OHR.2016.12.01.22 Published recently ... peer-reviewed journal from touchONCOLOGY, Andrew D Zelenetz ... of cancer care is placing an increasing burden ... expensive biologic therapies. With the patents on many ...
Breaking Biology Technology:
(Date:6/9/2016)... an innovation leader in attendance control systems is proud to announce the introduction of ... make sure the right employees are actually signing in, and to even control the ... ... ... ...
(Date:6/2/2016)... June 2, 2016 The Department of ... awarded the 44 million US Dollar project, for the ... Plates including Personalization, Enrolment, and IT Infrastructure , ... the production and implementation of Identity Management Solutions. Numerous renowned ... Decatur was selected for the most ...
(Date:5/24/2016)... superior patient care by providing unparalleled technology to leaders of the medical imaging industry. ... recently added to the range of products distributed by Ampronix. Photo - ... ... ... ...
Breaking Biology News(10 mins):